Date of enactment:
2023 Senate Bill 875 Date of publication*:
2023 WISCONSIN ACT
AN ACT to create 895.532 and 961.571 (1) (b) 4. of the statutes; relating to: excepting xylazine testing materials
from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administer-
ing xylazine testing products.
The people of the state of Wisconsin, represented in
senate and assembly, do enact as follows:
SECTION 1. 895.532 of the statutes is created to read:
895.532 Civil and criminal liability exemption;
xylazine testing products. (1) In this section, “xylazine
testing product” means any materials used or intended for
use in testing for the presence of xylazine or a xylazine
analog in a substance.
(2) Any person who distributes a xylazine testing
product is immune from civil or criminal liability for the
death of or injury to an individual caused by the adminis-
tration of the xylazine testing product.
(3) Any person who administers a xylazine testing
product according to manufacturer instructions provided
with the xylazine testing product is immune from civil or
criminal liability for the act, except for civil liability for
negligence in the performance of the act.
SECTION 2. 961.571 (1) (b) 4. of the statutes is created
to read:
961.571 (1) (b) 4. Any materials used or intended for
use in testing for the presence of xylazine or a xylazine
analog in a substance.
* Section 991.11, WISCONSIN STATUTES: Effective date of acts. “Every act and every portion of an act enacted by the legislature over the governor’s
partial veto which does not expressly prescribe the time when it takes effect shall take effect on the day after its date of publication.”